Sothema
A Santé stock listed on the Casablanca Stock Exchange.
What does Sothema do?
Société de Thérapeutique Marocaine (Sothema) is a Moroccan pharmaceutical laboratory founded in 1976, specializing in the manufacturing and marketing of medicines. The company produces generics and licensed products, manufactures for international laboratories and is developing a biotechnology business.
Source: company official website
Sothema performance
Stock performance over the main periods. Price as of July 16, 2026. Click a period to update the chart.
As of July 16, 2026, Sothema trades at 367.95 MAD, up 1.5% year to date.
Sothema ratios
Valuation and profitability ratios, as of July 15, 2026.
Ratios computed from the share price and the latest published financial statements.
The funds that own Sothema
87 Moroccan funds own Sothema, for 557.6 M MAD of combined assets, 4.0% of market cap. As of the latest published inventory (December 31, 2025).
The list of owning funds
The breakdown of the 87 owning funds and the stock's weight in each portfolio is for subscribers.
Detailed financial analysis of Sothema
Margins, EV/EBITDA, leverage, sector KPIs and earnings history, for subscribers.
Frequently asked questions about Sothema
Data updated automatically · last update: July 16, 2026
Analyze Sothema and the whole Casablanca market
Price, ratios, earnings, fund ownership and comparator, with a Yuna subscription.